Comparison of the effects of photodynamic therapy, intravitreal ranibizumab and combination for polypoidal choroidal vasculopathy under 1 + PRN regimen. [electronic resource]
Producer: 20180716Description: 144 p. digitalISSN:- 1471-2415
- Angiogenesis Inhibitors -- administration & dosage
- Choroid -- blood supply
- Choroid Diseases -- diagnosis
- Dose-Response Relationship, Drug
- Drug Therapy, Combination
- Female
- Fluorescein Angiography
- Follow-Up Studies
- Fundus Oculi
- Humans
- Intravitreal Injections
- Male
- Middle Aged
- Photochemotherapy -- methods
- Photosensitizing Agents -- therapeutic use
- Polyps -- diagnosis
- Porphyrins -- therapeutic use
- Prospective Studies
- Ranibizumab -- administration & dosage
- Time Factors
- Treatment Outcome
- Vascular Endothelial Growth Factor A -- antagonists & inhibitors
- Verteporfin
- Visual Acuity
No physical items for this record
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.